Breast Cancer

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA
FDA
FDA: New Vaccine Approved for Hepatitis B
11/13/2017
The US Food and Drug Administration has approved the first new vaccine for hepatitis B virus in over 25 years in the United States.
11/13/2017
FDA
FDA
FDA: New Vaccine Approved for Hepatitis B
11/13/2017
The US Food and Drug Administration has approved the first new vaccine for hepatitis B virus in over 25 years in the United States.
11/13/2017
FDA
FDA
FDA: New Vaccine Approved for Hepatitis B
11/13/2017
The US Food and Drug Administration has approved the first new vaccine for hepatitis B virus in over 25 years in the United States.
11/13/2017
venous thromboembolism
venous thromboembolism
FDA Approves New Dose for VTE Drug
11/01/2017
The US Food and Drug Administration recently approved a new dosing option for patients receiving treatment for recurrent venous thromboembolism.
11/01/2017
venous thromboembolism
venous thromboembolism
FDA Approves New Dose for VTE Drug
11/01/2017
The US Food and Drug Administration recently approved a new dosing option for patients receiving treatment for recurrent venous thromboembolism.
11/01/2017
venous thromboembolism
venous thromboembolism
FDA Approves New Dose for VTE Drug
11/01/2017
The US Food and Drug Administration recently approved a new dosing option for patients receiving treatment for recurrent venous thromboembolism.
11/01/2017
FDA Alerts
FDA Alerts
FDA Approves New Option for Generalized Myasthenia Gravis
10/25/2017
The US Food and Drug Administration has expanded the approval of a drug to include patients with generalized myasthenia gravis.
10/25/2017
FDA Alerts
FDA Alerts
FDA Approves New Option for Generalized Myasthenia Gravis
10/25/2017
The US Food and Drug Administration has expanded the approval of a drug to include patients with generalized myasthenia gravis.
10/25/2017
FDA Alerts
FDA Alerts
FDA Approves New Option for Generalized Myasthenia Gravis
10/25/2017
The US Food and Drug Administration has expanded the approval of a drug to include patients with generalized myasthenia gravis.
10/25/2017
Diabetes Q&A
Diabetes Q&A
FDA Approves Once-Weekly Diabetes Option
10/23/2017
The FDA has approved a new once-weekly, extended-release option for the treatment of adults with type 2 diabetes and uncontrolled blood sugar levels.
10/23/2017